Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-037695
Filing Date
2019-06-18
Accepted
2019-06-18 16:28:20
Documents
1
Period of Report
2019-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3893
  Complete submission text file 0001209191-19-037695.txt   5304
Mailing Address 1865 PALMER AVE, SUITE 104 LARCHMONT NY 10538
Business Address
GABRIELI CHRISTOPHER (Reporting) CIK: 0001181553 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38137 | Film No.: 19903915

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

EIN.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations